| pubmed-article:16301974 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16301974 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:16301974 | lifeskim:mentions | umls-concept:C0040038 | lld:lifeskim |
| pubmed-article:16301974 | lifeskim:mentions | umls-concept:C0348013 | lld:lifeskim |
| pubmed-article:16301974 | pubmed:issue | 19 Pt 2 | lld:pubmed |
| pubmed-article:16301974 | pubmed:dateCreated | 2005-11-22 | lld:pubmed |
| pubmed-article:16301974 | pubmed:abstractText | Adequate initial anticoagulant treatment is required to prevent thrombus growth and recurrence. Intravenous unfractionated heparin is being replaced by low-molecular-weight heparin as the anticoagulant of choice for initial treatment of venous thromboembolism. Vitamin K antagonists remain the only oral anticoagulant available (target international normalized ratio: 2.5). The duration of therapy should be individualized according to the risk of recurrence and the risk of bleeding. Three months of treatment is usually adequate if thrombosis was provoked by a reversible risk factor such as surgery. For patients with unprovoked ("idiopathic") thrombosis, anticoagulant treatment for at least 6 months is indicated. For patients with a recurrence of venous thromboembolism or with an irreversible risk factor such as cancer, indefinite anticoagulant therapy is recommended. Long-term treatment with low-molecular-weight heparin is usually preferable for patients with active cancer. Systemic thrombolysis is indicated for patients with massive pulmonary embolism but controversy persists for those with isolated right ventricular dysfunction. | lld:pubmed |
| pubmed-article:16301974 | pubmed:language | fre | lld:pubmed |
| pubmed-article:16301974 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16301974 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16301974 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16301974 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16301974 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16301974 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16301974 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:16301974 | pubmed:issn | 0755-4982 | lld:pubmed |
| pubmed-article:16301974 | pubmed:author | pubmed-author:MeyerGG | lld:pubmed |
| pubmed-article:16301974 | pubmed:author | pubmed-author:SanchezOO | lld:pubmed |
| pubmed-article:16301974 | pubmed:author | pubmed-author:SorsHH | lld:pubmed |
| pubmed-article:16301974 | pubmed:author | pubmed-author:WermertDD | lld:pubmed |
| pubmed-article:16301974 | pubmed:author | pubmed-author:AllainY-MYM | lld:pubmed |
| pubmed-article:16301974 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16301974 | pubmed:day | 5 | lld:pubmed |
| pubmed-article:16301974 | pubmed:volume | 34 | lld:pubmed |
| pubmed-article:16301974 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16301974 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16301974 | pubmed:pagination | 1427-34 | lld:pubmed |
| pubmed-article:16301974 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16301974 | pubmed:meshHeading | pubmed-meshheading:16301974... | lld:pubmed |
| pubmed-article:16301974 | pubmed:meshHeading | pubmed-meshheading:16301974... | lld:pubmed |
| pubmed-article:16301974 | pubmed:meshHeading | pubmed-meshheading:16301974... | lld:pubmed |
| pubmed-article:16301974 | pubmed:meshHeading | pubmed-meshheading:16301974... | lld:pubmed |
| pubmed-article:16301974 | pubmed:meshHeading | pubmed-meshheading:16301974... | lld:pubmed |
| pubmed-article:16301974 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16301974 | pubmed:articleTitle | [Treatment of venous thromboembolic disease]. | lld:pubmed |
| pubmed-article:16301974 | pubmed:affiliation | Service de pneumologie, soins intensifs, Hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Faculté de médecine Paris V René Descartes, Paris. olivier.sanchez@hop.egp.aphp.fr | lld:pubmed |
| pubmed-article:16301974 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16301974 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:16301974 | pubmed:publicationType | Review | lld:pubmed |
